APA

Gay F., Rajkumar S. V., Coleman M., Kumar S., Mark T., Dispenzieri A., Pearse R., Gertz M. A., Leonard J., Lacy M. Q., Chen-Kiang S., Roy V., Jayabalan D. S., Lust J. A., Witzig T. E., Fonseca R., Kyle R. A., Greipp P. R., Stewart A. K. & Niesvizky R. (20101001). Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma. : American journal of hematology.

Chicago

Gay Francesca, Rajkumar S Vincent, Coleman Morton, Kumar Shaji, Mark Tomer, Dispenzieri Angela, Pearse Roger, Gertz Morie A, Leonard John, Lacy Martha Q, Chen-Kiang Selina, Roy Vivek, Jayabalan David S, Lust John A, Witzig Thomas E, Fonseca Rafael, Kyle Robert A, Greipp Philip R, Stewart A Keith and Niesvizky Ruben. 20101001. Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma. : American journal of hematology.

Harvard

Gay F., Rajkumar S. V., Coleman M., Kumar S., Mark T., Dispenzieri A., Pearse R., Gertz M. A., Leonard J., Lacy M. Q., Chen-Kiang S., Roy V., Jayabalan D. S., Lust J. A., Witzig T. E., Fonseca R., Kyle R. A., Greipp P. R., Stewart A. K. and Niesvizky R. (20101001). Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma. : American journal of hematology.

MLA

Gay Francesca, Rajkumar S Vincent, Coleman Morton, Kumar Shaji, Mark Tomer, Dispenzieri Angela, Pearse Roger, Gertz Morie A, Leonard John, Lacy Martha Q, Chen-Kiang Selina, Roy Vivek, Jayabalan David S, Lust John A, Witzig Thomas E, Fonseca Rafael, Kyle Robert A, Greipp Philip R, Stewart A Keith and Niesvizky Ruben. Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma. : American journal of hematology. 20101001.